Abstract

CLC Number:

R964

张均田，刘少林，蒋学英，楚世峰. [J]. Acta Neuropharmacologica, 2015, 5(1): 1-9.

[1] Michael S Gazzaniga, Richard B Ivry, George Ronald Mangun. 周晓林，高定国等译. Cognitive neuroscience, the biology of the mind[M]. 第三版. 北京: 中国轻工业出版社, 2013.

[2] 刘芳, 褚波. 大脑与认知（修订版）[M]. 北京: 电子工业出版社, 2012.

[3] 唐孝威, 孙达, 水仁德, 等. 认知科学导论[M]. 北京: 科学出版社, 2007.

[4] Bernard J Baars, Nicole M Gage. Cognition, brain, and consciousness, second edition: introduction to cognitive neuroscience[M].第二版. 北京: 科学出版社, 2012.

[5] Sweatt J D. Mechanism of memory(second ed)[M].第二版. 北京: 科学出版社.

[6] 史忠植编著.认知科学[M]. 安徽: 中国科学技术大学出版社, 2008.

[7] 杨藻宸. 药理学总论[M]. 北京: 人民卫生出版社, 1989: 1-9.

[8] 张淑华, 朱启华, 杜庆东, 等.认知科学基础[M].北京: 科学出版社, 2007.

[9] 陈乃宏.神经递质与神经疾患[M].北京: 中国协和医科大学出版社, 2012： 1-18.

[10] 张庆柱, 张均田.书写世界现代医学史的巨人们—历届诺贝尔生理学或医学获奖者的传奇业绩和人生[M].北京: 中国协和医科大学出版社, 2006.

[11] 张均田, 张庆柱, 张永祥.神经药理学[M].北京: 人民卫生出版社, 2008.

[12] 韩济生.神经科学原理 [M]. 第二版. 北京: 北京医科大学出版社, 1999：268-283.

[13] 蔡禄. 表观遗传学前沿 [M].北京: 清华大学出版社, 2012.

[14] Day J J, Sweatt J D. Epigenetic treatments for cognitive impairments[J]. Neuropsycopharmacology, 2012, 37(1): 247-260.

[15] 张均田. 认知过程中的表观遗传学机制[J].中国药理学通报, 2015, 3(1): 1-6.

[16] 楚世峰, 张均田. 人参皂甙Rg1多靶点作用的共有机制[R].全国补益药专业委员会学术讨论会上大会报告, 太原, 2014.

[17] 黄倩, 楚世峰, 张均田. 人参皂甙Rg1的抗抑郁作用及其作用机制[J].神经药理学学报, 2014, 3(1): 1-11.

[18] 张均田.发现新药的药理学基础[M].北京: 北京化工出版社, 2002.

[19] 王玉珠, 王永胜, 楚世峰, 等. 人参皂甙Rg1促智信号转导途径研究[J].中国药理学通报, 2008, 24: 740-743.

[20] Chang Yi, Huang Wei-jan, Tien Lu-Tai, et al. Ginsenoside Rg1 and Rb1 enhance glutamate release through activation of protein A in rat cerebrocortical nerve terminals(synaptosomes) [J]. Eur J. Pharmacol, 2008, 578(1): 28-36.

[21] 张均田. 人参冠百草 [M]. 第二版.北京: 北京化学工业出版社, 2012：328-334.

[22] Hu Jin-Feng, Xue Wei, Ning Na, et al. Ginsenoside Rg1 activated CaMKⅡα mediated extracellular signal-regulated kinase/mitogen activated protein kinase signaling pathway[J]. Acta Pharmacol Sin, 2008, 29(9): 1119-1126.

[23] 张均田, 杜冠华. 现代药理实验方法 [M]. 第二版. 北京: 中国协和医科大学出版社, 2013：1326-1346.

[24] 中国药理学会编. 药理学学科发展报告（2010-2011）[M].北京: 科学出版社, 2011：127-142.

[25] Yang Y, Zhang J T, Shi C Z, et al. Study on the nootropic mechanism of ginsenoside Rb1 and Rg1. Influence on mouse brain development[J]. Acta Pharma Sin, 1994, 29(4): 241-245.

[26] Zhang J T. The retrospection and prospect of ginseng research[J]. Acta Pharmacol Sin, 1995, 20: 321-325.

[27] 申丽红, 张均田. 胎鼠神经干细胞培养方法的建立及药物对干细胞增殖的影响[J]. 药学学报, 2003, 38(10): 735-738.

[28] Shen Li-Hong, Zhang Jun-Tian. Ginsenoside Rg1 promotes proliferation of hippocampal progenitor cells[J]. Neurol Res, 2004, 26(4): 422-428.

[29] Shen Li-hong, Zhang Jun-tian. NMDA receptor and iNOS are involved in the effects of ginsenoside Rg1 on hippocampal neurogenesis in ischemic gerbils[J]. Neurol Res, 2007, 29(3): 270-273.

[30] 张均田. 人参冠百草 [M]. 第二版. 北京: 北京化学工业出版社, 2012：295-306.

[31] Tang M, Feng W, Zhang Y, et al. Salvianolic acid B improves motor function after cerebral in rats[J]. Behav Pharmacol, 2006, 17(5-6): 493-498.

[32] Tang MK. Neuroprotective effects of salvianolic acid B. The chemistry, pharmacology and clinical therapeutic effects of Danshen( edited-in –chief by Zhang JT, Du GH)[M].化学工业出版社, 2013: 174-185.

[33] Zhong Jing, Qin Zhuan-di, Tang Ming-ke, et al. Sal B stimulates neurogenesis and angiogenesis in vitro and vivo[J]. Chinese Pharmacologist, 2005, 22(4): 9-10.

[34] Ing-Shiow Lay, Jen-Hwey Chiu, Shiao Ming-Shi, et al. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line[J]. Planta Med, 2003, 69(1): 26-32.

[35] Zhang Jun-Tian. The Chemistry and biological activates of (-)Clausenamide[M]. Beijing: Chemical Industry Press, 2013: 64-72.

[36] Jiang Xue-ying, Zhang Jun-tian. Study on the nootropic mechanism of (-)clausenamide-influence on the formation of synapses in mouse brain[J]. J Asian Nat Prod Res, 1998, 1(1): 53-58.

[37] Ning Na, Hu Jin-Feng, Sun Jian-Dong, et al. (-)Clausenamide facilitates synaptic transmission at hippocampal Schaffer collateral-CA1 synapses[J]. Eur J Pharmacol, 2012, 682(1-3): 50-55.

[38] 帕特丽夏.法拉, 卡拉琳.帕特森编, 户晓辉译.剑桥年度主题讲座：记忆[M].北京: 华夏出版社, 2011：128-129.

[39] Atkins C M, Selcher J C, Petraitis J J, et al. The MAPK cascade is required for mammalian associative learning[J]. Nat Neurosci, 1998, 1(7): 602-609.

[40] Emiliana Borrelli, Eric J Nestler, C David Allis, et al. Decoding the epigenetic language of neuronal plasticity[J]. Neuron, 2008, 60(6): 961-974.

[41] Brian Raught, Anne-Claude Gingras, Nahum Sonenberg. The target of rapamycin(TOR) proteins[J]. Proc Natl Acad Sci USA, 2001, 98(13): 7037-7044.

[42] Johannes Gräff, Isabelle M Mansuy. Epigenetic codes in cognition and behaviour[J]. Behav Brain Res, 2008, 192(1): 70-87.

[43] Paul L Greer, Michael E Greenberg. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function[J]. Neuron, 2008, 59（6）: 846-860.

[44] Jones M W, Errington M L, French P J, et al. A requirement for the immediate early gene Zif268 in the expression of Late LTP and long term memories[J]. Nat Neurosci, 2001, 4(3): 289-296.

[45] Karl Deisseroth, Richard W Tsien. Dynamic multiphosphorylation passwords for activity-dependent gene expression[J]. Neuron, 2002, 34: 179-182.

[46] Andreas Wenzel, Jean Marc Fritschy, Hanns Mohler, et al. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B and NR2C subunit proteins[J]. J Neurochem, 1997, 68(2): 469-478.

[47] Liu Li-dong, Wong Tak Pan, Mario F Pozza, et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity[J]. Science, 2004, 304(5763): 1021-1024.

[48] Lee H K, Barbarosie M, Kameyama K, et al. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity[J]. Nature, 2000, 405(6789): 955-959.

[49] Sheeja Navakkode, Sreedharsh Sajikumar, Julietta Uta Frey. The type Ⅳ-specific phosphor- diesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging[J]. J Neurosci, 2004, 24(35): 7740-7744.

[50] Tomok Ishibashi, Kelly A Dakin, Beth Stevens, et al. Astrocytes promote myelination in response to electrical impulses[J]. Neuron, 2006, 49(6): 823-832.

[51] Sara L Bengtsson, Zoltan Nagy, Stefan Skare, et al. Extensive paino practicing has regionally specific effects on white matter development[J]. Nat Neurosci, 2005, 8(9): 1148-1150.

[52] Martins D, Tavares I, Morgado C. “Hotheaded”: the role of TRPV1 in brain functions[J]. Neuropharmacology, 2014, 85: 151-157.

[53] Kauer J A,Gibson H E. Hot flash: TRPVchannels in the brain[J]. Trends Neurosci, 2009, 32(4): 215-224.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	SUN Yi，TAN Bo，SU Rui-bin. Biased Ligand——Novel Paradigm for Opioid Analgesics [J]. Acta Neuropharmacologica, 2018, 8(2): 1-7.
[2]	WANG Jin-hui，HUANG Li，CHEN Na. Ischemic Injury of Cortical GABAergic Neurons：Vulnerability，Mechanism and Pathological Impacts [J]. Acta Neuropharmacologica, 2018, 8(2): 8-25.
[3]	DU Guan-hua，ZHANG Wen，DU Li-da，MA Yin-zhong，LI Li，WANG Yue-hua. New Strategies for the Drug Development of Anti-cerebral Ischemia —Advances in the Etiology and Drug Development of Acute Cerebral Ischemia [J]. Acta Neuropharmacologica, 2018, 8(1): 1-8.
[4]	LIN Zhi-bin. Pharmacological Progress of Ganoderma on Anti-aging and Anti-Alzheimer’s Disease [J]. Acta Neuropharmacologica, 2018, 8(1): 9-15.
[5]	MA Juan，ZHANG Fa-li，QIAN Zhong-ming. Hepcidin and Iron-associated Neurodegenerative Disorders [J]. Acta Neuropharmacologica, 2018, 8(1): 16-22.
[6]	YANG Yan-fei，HUANG Zhi-li. Recent Advance on Sleep-Wake Regulation Based on Novel Techniques for Specific Manipulations of Neuron Activities [J]. Acta Neuropharmacologica, 2018, 8(1): 23-34.
[7]	WANG Yun，ZHEN Xue-chu. An Update on Allosteric Modulator of Sigma-1 Receptors: Potential Applications [J]. Acta Neuropharmacologica, 2018, 8(1): 35-44.
[8]	XIAO Ting，MA Tian-yang，XU Xiang-qing，WANG Ke-wei. Establishment and Behavior Evaluation of Rat Chronic Unpredictable Mild Stress and Mouse Social Defeat Models [J]. Acta Neuropharmacologica, 2018, 8(1): 45-53.
[9]	ZAN Gui-ying，SUN Xiang，LI Qing-lin，LIU Jing-gen. Research Progress of the Role and Underlying Mechanism of Dynorphin/κ Opioid Receptor in the Development of Depression [J]. Acta Neuropharmacologica, 2018, 8(1): 54-64.
[10]	ZHANG Kuo，YANG Jing-yu，WU Chun-fu. Progress on Pathophysiology and Animal Models of Depression [J]. Acta Neuropharmacologica, 2017, 7(4): 8-16.
[11]	REN Jing，ZHANG Dan-shen. Progress in Research of Brain Targeting Ligand for Nano-scale Drug Delivery Systems [J]. Acta Neuropharmacologica, 2017, 7(4): 17-25.
[12]	PANG Xue-bo，XUE Qian，ZOU Yu-an. The Research Progress of Plasma Lipoprotein-associated Phospholipase A2 and Ischemic Stroke [J]. Acta Neuropharmacologica, 2017, 7(4): 31-35.
[13]	WAN Ye，GUO Chun-yan，LI Yong-min. Research Progress of Traditional Chinese Medicine in Parkinson’s Disease [J]. Acta Neuropharmacologica, 2017, 7(4): 36-42.
[14]	WANG Cui, GUO Tong-lin, SHEN Li-xia. Study on the Neuroprotective Effects of Phytoestrogens in Alzheimer’s Disease [J]. Acta Neuropharmacologica, 2017, 7(4): 43-52.
[15]	BAI Yan-chang，JIA Yan-li，SONG Ya-xue，WANG Jian-hua. Advance of Functional Magnetic Resonance Imaging of Brain in Alzheimer’s Disease [J]. Acta Neuropharmacologica, 2017, 7(3): 6-11.